Christoph Huber

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Christoph Huber
Christoph Huber2016.JPG
Born Liestal, Switzerland
Residence Geneve, Switzerland
Occupation Cardiac Surgeon; Medical device inventor; Author

Christoph Huber MD, FMH,FECTS is professor and Head of Division of Cardiac and Vascular Surgery at the University Hospital Geneva, Switzerland.[1][2] He also maintains an active research program,[3] is an inventor, book author and entrepreneur, having founded the company Endoheart AG.[4]

Biography[edit]

Christoph Huber completed his Dr. med. at the University Medical School in Basel, Switzerland, General Surgery Residency at the District Hospital Biel and Cardiovascular Residency at the University Hospital Bern, Inselspital, Switzerland.[1] Between 2002-07/08, Huber attended at the University Hospital Lausanne (including a senior cardiac surgical clinical fellowship 2004-05 at Brigham and Women’s Hospital, Harvard Medical School, Boston, USA) and Great Ormond Street Hospital, London, UK (Senior Fellow Congential Cardiac Surgery); returning to University Hospital Bern in 2009 as a Senior Consultant Cardiovascular Surgeon (MD, FMH), Director of the Surgical Transcatheter Valve Implantation (TAVI) Program, lecturer, and Medical Superintendent of adult cardiac surgery.[1][5] In 2016, Huber became the Head of Division Cardiac and Vascular Surgery (Médecin-chef de service) at the University Hospital Geneva (HUG).[1][2] Huber also published a textbook on transcatheter valve therapies (TCVT) in 2009.[5]

Inventor[edit]

Huber developed the transapical (TA) TAVI [5] in 2004 which introduced a less invasive antegrade, versus transfemoral/TF retrograde, approach to the heart,[6][7][8][9] and his later research, into a percutaneious transapical TAVI platform, led to his invention of the first successful experimental closure device (TA Plug).[7][8][10] Huber also opened a startup company [4] and assisted in the development of the Acurate TA (Symetis) device which received CE approval in 2011.[11][12][13]

Awards[edit]

Sept. 2014 - Swiss SIWF-Award: Distinction as best Swiss teacher for Cardiac Surgery[14]

May 2009 - National Research Prize, Swiss National Heart Foundation: In recognition for development of the transapical TAVI approach (Trans Catheter Valve Replacement of the Aortic Valve - The Direct Access Trans Apical Procedure)[5][15]

Sept. 2005 - St. Jude Medical/C Walton Lillehei Young Investigator's Award, EACTS (19th Annual Meeting, Barcelona, Spain)[1]

Feb. 2004 - ISES Peripheral Vascular Fellow’s Forum Award (2004 Forum, Scottsdale, Arizona): For presentation of ‘New tools for new goals (Ultrasound navigation through the heart for off-pump aortic valved stent implantation)[1]

Oct. 2003 - St. Jude Medical/C. Walton Lillehei Young Investigator’s Award, EACTS (17th Annual Meeting, Vienna, Austria): Do Valved Stent Compromise Coronary Flow?[1]

Societies[edit]

Swiss Society of Thoracic-Cardiac and Vascular Surgery (SGHC - Board Member)[16]

European Association For Cardio-Thoracic Surgery (EACTS - Chair Acquired Cardiac Disease Domain/Moderator Techno College)[17]

References[edit]

  1. ^ a b c d e f g Christoph Huber entry at CTSnet Page accessed May 22, 2016
  2. ^ a b University Hospital Geneva website Page accessed May 22, 2016
  3. ^ Database Christoph Huber research/citations/publications
  4. ^ a b Moneyhouse Registry database – Huber-EndoHeart Page accessed April 18, 2016
  5. ^ a b c d Profile Huber - University Hospital Bern Archived 2016-05-07 at the Wayback Machine. Page accessed May 22, 2016
  6. ^ Do valved stents compromise coronary flow?, Oxford Journals – January 2004 (Huber early research) Page accessed April 18, 2016
  7. ^ a b TA Plug, European Assoc. for Cardio-Thoracic Surgery - EACTS – October 2012 (PDF link – refer “TA Plug” - Huber as inventor of transapical (TA) – page 1/missing last lines and not found in rest of PDf) Page accessed May 22, 2016
  8. ^ a b Transapical access closure: the TA PLUG device, Oxford Journals – June 2013 (Huber 2012 research, presented EACTS Oct. 2012; connects Huber with Swiss National Grant (3200B-113437), Edwards Lifesciences, Symetis, Medtronic) Page accessed May 22, 2016
  9. ^ Transapical vs. transfemoral aortic valve implantation, Thomas Walther – July 2012 Page accessed May 22, 2016
  10. ^ Valved stents for transapical pulmonary valve replacement, Journal of Thoracic and Cardiovascular Surgery, 2009 (Huber and valved stent development) Page accessed May 22, 2016
  11. ^ Cardiovascular News – October 2013 (Symetis CE Approval; connects T Walther, device background Page accessed April 18, 2016
  12. ^ Huber research link to Symetis database Page accessed April 18, 2016
  13. ^ Transapical transcatheter aortic valve implantation using the second-generation self-expanding Symetis ACURATE TA valve, Oxford Journal – October 2014 (with Huber connection to Symetis, Edwards Lifesciences, Medtronic Page accessed April 18, 2016
  14. ^ Bern Hospital – Research Awards Page accessed April 18, 2016
  15. ^ Swiss National Heart Foundation (SNF) Archived 2016-04-26 at the Wayback Machine. Page accessed April 18, 2016
  16. ^ Swiss Society of Thoracic-Cardiac and Vascular Surgery Board Members Page accessed April 18, 2016
  17. ^ EACTS Report/29th Annual Meeting – October 2015 (PDF - refer p. 28) Page accessed May 22, 2016